14.31
Schlusskurs vom Vortag:
$14.00
Offen:
$13.89
24-Stunden-Volumen:
869.91K
Relative Volume:
0.55
Marktkapitalisierung:
$1.85B
Einnahmen:
$3.31B
Nettoeinkommen (Verlust:
$98.90M
KGV:
-23.34
EPS:
-0.6131
Netto-Cashflow:
$195.60M
1W Leistung:
+9.32%
1M Leistung:
+21.27%
6M Leistung:
-31.37%
1J Leistung:
-32.56%
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SGRY
Surgery Partners Inc
|
14.31 | 1.81B | 3.31B | 98.90M | 195.60M | -0.6131 |
|
HCA
Hca Healthcare Inc
|
478.13 | 109.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
191.26 | 17.23B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.18 | 12.79B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
197.55 | 11.69B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
179.72 | 11.13B | 17.36B | 1.51B | 849.25M | 23.15 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Allstate sues Surgery Partners, alleges Florida surgery centers ran billing scheme - Insurance Business
Benchmark Maintains Surgery Partners (SGRY) Buy Recommendation - MSN
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know - Yahoo Finance
Surgery Partners Q1 Earnings: A Test of Resilience Amid Growth - BriefGlance
Allstate Says Fla. Surgery Centers Padded Bills For Care - Law360
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details - The Manila Times
Surgery Partners to Announce First Quarter 2026 Financial Results on May 5, 2026 - Quiver Quantitative
Surgery Partners posts Q1 results May 5, webcast at 8:30 ET - Stock Titan
Deals tracker: ChristianaCare enters cardiology joint venture - Modern Healthcare
SGRY Stock Price, Quote & Chart | SURGERY PARTNERS INC (NASDAQ:SGRY) - ChartMill
Cantor Fitzgerald reiterates Surgery Partners stock rating on volumes - Investing.com
Cantor Fitzgerald reiterates Surgery Partners stock rating on volumes By Investing.com - Investing.com Canada
Surgery Partners Inc at Barclays Global Healthcare Conference Transcript - GuruFocus
Responsive Playbooks and the SGRY Inflection - Stock Traders Daily
Can Surgery Partners (SGRY) Board Shake-Up Reframe Its Debt-Heavy, Volume-Challenged Growth Narrative? - simplywall.st
Surgery Partners (NASDAQ:SGRY) Stock Rating Lowered by Zacks Research - MarketBeat
EPS Watch: What is Surgery Partners Incs 5 year growth outlookWeekly Profit Recap & Safe Entry Zone Tips - baoquankhu1.vn
Cantor Fitzgerald reiterates Surgery Partners stock Overweight rating By Investing.com - Investing.com Canada
Can Softer Volumes and Higher Leverage Reshape Surgery Partners’ (SGRY) 2026 Reset Narrative? - Yahoo Finance
3 Reasons to Avoid SGRY and 1 Stock to Buy Instead - Yahoo Finance
Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of "Moderate Buy" by Analysts - marketbeat.com
Decoding the Ambulatory Surgery Center Market: Competitive Positioning of Top Companies - The National Law Review
Surgery Partners Inc (1SP.DU) balance sheet - Yahoo Finance UK
Understanding the Setup: (SGRY) and Scalable Risk - Stock Traders Daily
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES - PR Newswire
JPMorgan Chase & Co. Grows Stock Holdings in Surgery Partners, Inc. $SGRY - marketbeat.com
SG Americas Securities LLC Purchases 549,945 Shares of Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners stock hits 52-week low at $11.53 By Investing.com - Investing.com Australia
Surgery Partners (SGRY) price target decreased by 24.02% to 19.73 - MSN
(SGRY.O) | Stock Price & Latest News - Reuters
Vanguard disaggregates holdings; reports 0 shares in Surgery Partners (SGRY) - Stock Titan
Surgery Partners (NASDAQ:SGRY) Reaches New 1-Year LowWhat's Next? - MarketBeat
Surgery Partners stock hits 52-week low at $11.53 - investing.com
SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- - GlobeNewswire
Aug PostEarnings: Should value investors consider Surgery Partners Inc2026 Update & Capital Efficiency Focused Ideas - baoquankhu1.vn
A Look At Surgery Partners (SGRY) Valuation After Recent Share Price Weakness - Sahm
Quarterly Risk: What are analysts price targets for Surgery Partners Inc2026 Action & Verified Short-Term Plans - baoquankhu1.vn
Published on: 2026-03-23 00:20:23 - baoquankhu1.vn
SGRY SEC FilingsSurgery Partners Inc 10-K, 10-Q, 8-K Forms - Stock Titan
The Technical Signals Behind (SGRY) That Institutions Follow - Stock Traders Daily
Hudson Bay Capital Management LP Sells 133,637 Shares of Surgery Partners, Inc. $SGRY - marketbeat.com
Surgery Partners stock hits 52-week lowhere's why - MSN
SGRY Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates - GlobeNewswire
Surgery Partners stock hits 52-week low at 12.22 USD By Investing.com - Investing.com South Africa
Surgery Partners Inc (SGRY) Trading Down 2.45% on Mar 18 - GuruFocus
Surgery Partners (NASDAQ:SGRY) Hits New 12-Month LowTime to Sell? - MarketBeat
Surgery Partners stock hits 52-week low at 12.22 USD - Investing.com
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):